HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

M Taniguchi Selected Research

Leukotriene E4

1/2009Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
8/2008Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia.
4/2008Salicylamide-induced anaphylaxis: increased urinary leukotriene E4 and prostaglandin D2 metabolite.
8/2004Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge.
6/2004Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge.
6/2003Nasal blockage and urinary leukotriene E4 concentration in patients with seasonal allergic rhinitis.
11/2001Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
11/2001[Clinical significance of measurement of urinary leukotriene E4 in asthmatic patients without attack].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


M Taniguchi Research Topics

Disease

11Ischemia
03/2003 - 12/2000
10Asthma (Bronchial Asthma)
12/2015 - 11/2000
10Neoplasms (Cancer)
05/2005 - 01/2000
8Infection
01/2005 - 01/2000
7Neoplasm Metastasis (Metastasis)
06/2012 - 01/2000
7Reperfusion Injury
03/2003 - 02/2001
4Anoxia (Hypoxia)
08/2013 - 01/2001
4Inflammation
09/2010 - 01/2001
4Hyperplasia
07/2006 - 02/2001
3Anaphylaxis (Anaphylactic Shock)
10/2014 - 04/2008
3Stomach Neoplasms (Stomach Cancer)
06/2012 - 05/2000
3Parkinson Disease (Parkinson's Disease)
03/2010 - 05/2000
3Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
10/2001 - 06/2001
2Lymphoma (Lymphomas)
01/2015 - 09/2000
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2013 - 06/2000
2Renal Insufficiency (Renal Failure)
08/2010 - 02/2006
2Atrophy
01/2008 - 12/2001
2Liver Diseases (Liver Disease)
01/2008 - 01/2000
2Hyperparathyroidism
06/2007 - 07/2006
2Chronic Hepatitis C
10/2006 - 01/2005
2Aspirin-Induced Asthma
06/2004 - 11/2001
2Rhinitis
06/2003 - 11/2000
2Body Weight (Weight, Body)
09/2001 - 08/2000
2Hepatocellular Carcinoma (Hepatoma)
07/2001 - 11/2000
2Alzheimer Disease (Alzheimer's Disease)
05/2001 - 12/2000
2Autoimmune Diseases (Autoimmune Disease)
05/2001 - 06/2000
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2001 - 02/2001
2Melanoma (Melanoma, Malignant)
02/2001 - 01/2000
2Hepatitis
01/2000 - 01/2000
1Allergic Bronchopulmonary Aspergillosis
12/2015
1Food Hypersensitivity (Food Allergy)
10/2014
1Wheat Hypersensitivity (Wheat Allergy)
10/2014
1Periodontal Diseases (Periodontal Disease)
02/2014
1Shock
03/2013
1Adenocarcinoma
06/2012
1Obesity
05/2012
1End Stage Liver Disease
03/2012
1AIDS-Related Complex (ARC)
02/2012
1Experimental Arthritis
09/2008
1Pulmonary Eosinophilia (Eosinophilic Pneumonia)
08/2008
1Human Influenza (Influenza)
05/2008
1Fat Necrosis
06/2007
1Calciphylaxis
06/2007
1Fibrosis (Cirrhosis)
06/2007

Drug/Important Bio-Agent (IBA)

8Leukotriene E4IBA
01/2009 - 11/2001
8alpha-galactosylceramideIBA
05/2008 - 01/2000
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2012 - 11/2001
5LeukotrienesIBA
01/2009 - 11/2001
5T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2001 - 02/2000
5Interleukin-12 (IL 12)IBA
02/2001 - 01/2000
4Prostaglandin D2IBA
01/2009 - 11/2001
4Interleukin-4 (Interleukin 4)IBA
07/2005 - 01/2000
3AllergensIBA
12/2015 - 11/2000
3Messenger RNA (mRNA)IBA
07/2005 - 05/2000
3AntigensIBA
08/2001 - 01/2001
2Interleukin-2 (IL2)IBA
01/2015 - 02/2001
2Arachidonic Acid (Vitamin F)IBA
12/2011 - 10/2002
2Ribavirin (Virazole)FDA LinkGeneric
10/2006 - 01/2005
2Biological Markers (Surrogate Marker)IBA
10/2006 - 12/2005
2Calcium-Sensing ReceptorsIBA
07/2006 - 02/2006
2EicosanoidsIBA
12/2005 - 10/2002
2DinoprostIBA
12/2005 - 10/2002
2InterferonsIBA
01/2005 - 12/2000
2Phosphotransferases (Kinase)IBA
01/2003 - 05/2000
2Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2001 - 09/2000
2CholesterolIBA
08/2001 - 06/2001
2Presenilin-1IBA
05/2001 - 12/2000
2LigandsIBA
05/2001 - 01/2000
2LY 329722IBA
04/2001 - 02/2001
2Adenosine Triphosphate (ATP)IBA
04/2001 - 04/2001
2CytokinesIBA
02/2001 - 01/2001
2InterleukinsIBA
12/2000 - 02/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2000 - 05/2000
2PerforinIBA
09/2000 - 01/2000
1Immunoglobulin E (IgE)IBA
12/2015
1X-Linked Inhibitor of Apoptosis ProteinIBA
01/2015
1Cathepsin BIBA
01/2015
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
01/2015
1Protein HydrolysatesIBA
10/2014
1Soaps (Soap)IBA
10/2014
1AmylasesFDA Link
02/2014
1Histones (Histone)IBA
03/2013
1Phenobarbital (Luminal)FDA Link
06/2012
1megakaryocyte potentiating factorIBA
06/2012
1serum P-component (CIt)IBA
03/2012
1HydrogenIBA
02/2012
1LipoxinsIBA
12/2011
1Keratin-10IBA
09/2010
1Interleukin-17 (Interleukin 27)IBA
09/2008
1Eosinophil-Derived NeurotoxinIBA
08/2008
1Carbon MonoxideIBA
08/2008
1salicylamideIBA
04/2008
1CalciumIBA
06/2007

Therapy/Procedure

3Transplantation (Transplant Recipients)
08/2013 - 01/2000
3Renal Dialysis (Hemodialysis)
08/2010 - 03/2000
2Transplants (Transplant)
01/2008 - 01/2000
2Catheters
12/2001 - 01/2000
2General Anesthesia
03/2000 - 01/2000
1Deep Brain Stimulation
03/2010
1Surgical Portacaval Shunt (Portacaval Anastomosis)
01/2008